US · Healthcare · Medical Care Facilities
EPS came in at 9.58 against a street estimate of 5.26 — a beat of 82.1%.
Analysts rate Nutex Health Inc a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $288.20.
| Fund | Stake |
|---|---|
| Pertento Partners LLP | 6.59% |
| BlackRock Inc | 5.95% |
| American Century Companies Inc | 3.47% |
| Vanguard Capital Management, LLC | 3.15% |
| Geode Capital Management, LLC | 1.93% |
| State Street Corp | 1.91% |
| D. E. Shaw & Co LP | 1.42% |
| UBS Group AG | 1.14% |
| Document | Date |
|---|---|
| Company announcement · Q3 2026 NUTEX HEALTH INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Filing Date: September 10, 2026 • Company: Nutex Health Inc. • Stock Ticker: NUTX (traded on | 2026-09-11 |
| Current report · Q3 2026 NUTEX HEALTH INC. - FORM 8-K SUMMARY RISKS & NEGATIVES • Cybersecurity Incident: Company experienced unauthorized access to its computer network wit | 2026-08-31 |
| Company announcement · Q3 2026 NUTEX HEALTH INC. — FORM 8-K SUMMARY HEADLINE NUMBERS • Company: Nutex Health Inc. (ticker: NUTX, NASDAQ) • Report date: August 24, 2026 • Headquart | 2026-08-24 |
| Company announcement · Q3 2026 NUTEX HEALTH INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • No financial numbers disclosed in this filing • Document is a regulatory notification, not an | 2026-08-13 |
| Quarterly report · Q2 2026 NUTEX HEALTH INC. – FORM 10-Q SUMMARY Quarter Ended June 30, 2026 --- HEADLINE NUMBERS • Total Revenue (6 months): $427.2 million vs. $455.8 millio | 2026-08-06 |
| Results announced · Q3 2026 NUTEX HEALTH INC. – Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Net Income (6 months): $112.6 million attributable to Nutex Health, up from $3.5 mil | 2026-08-06 |
| Quarterly report · Q1 2026 NUTEX HEALTH INC. – Q1 2026 FORM 10-Q SUMMARY HEADLINE NUMBERS • Total Revenue (Q1 2026): $216.5 million, up from $211.8 million in Q1 2025 (+2.2%) | 2026-04-30 |
| Proxy statement · Q1 2026 NUTEX HEALTH INC. – 2026 PROXY SUMMARY --- WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Re-elect seven directors for one-year terms: Thomas T. Vo, | 2026-03-13 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Split | 1 : 10 effective Jul 3, 2024 | 2024-07-03 |
| Split | 1 : 15 effective Apr 10, 2024 | 2024-04-10 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Nutex Health Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.